Related Experiment Video
Updated: Jan 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Acute kidney injury disrupts cardiac remodeling via SerpinA3N
Gowda Sreerama Pramod1, Stanley Qu1, Runze Ni1
1Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Insights
Acute kidney injury (AKI) can harm the heart. This study reveals AKI upregulates SerpinA3N, inhibiting Granzyme B, which promotes heart fibrosis and remodeling.
Area of Science:
- Cardiology
- Nephrology
- Molecular Biology
Background:
- Cardiorenal syndrome type 3 (CRS-3), or acute reno-cardiac syndrome, links acute kidney injury (AKI) to cardiac dysfunction.
- The precise mechanisms driving AKI-induced cardiac injury remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms behind myocardial pro-fibrotic factor development and cardiac remodeling following AKI.
- To explore the role of SerpinA3N and Granzyme B in AKI-related cardiac changes.
Main Methods:
- Utilized a mouse model of AKI induced by bilateral pedicle clamping and reperfusion.
- Performed proteomic analysis (LC-MS) and RNA sequencing (RNA-seq) on heart tissue.
- Assessed serine protease activity, gene expression, protein levels, and cytokine expression in cardiac tissue and H9C2 cells.
Main Results:
- AKI significantly upregulated cardiac SerpinA3N expression, inversely correlating with serine protease (Granzyme B) activity.
- AKI induced pro-fibrotic factors, mitochondrial dysfunction, and inflammation in the heart.
- Inhibition of SerpinA3N using XAV939 in H9C2 cells enhanced Granzyme B activity.
Conclusions:
- AKI promotes cardiac fibrosis and adverse remodeling through SerpinA3N-mediated inhibition of Granzyme B activity.
- Modulating SerpinA3N levels may offer a therapeutic strategy to mitigate AKI-induced cardiac fibrosis and improve extracellular matrix composition.
Abstract:
Cardiorenal syndrome type 3 (CRS-3) also known as acute reno-cardiac syndrome, refers to a condition where acute kidney injury (AKI) leads to acute cardiac dysfunction or injury. The underlying mechanisms have not been elucidated. In the current study, we examined the potential mechanisms for the development of myocardial pro-fibrotic factors and cardiac remodeling in C57BL/6J mice after AKI. The mice were subjected to bilateral pedicle clamping for 30 min followed by 24 h of reperfusion. Heart tissue was collected from control (Ctrl) and AKI mice and subjected to proteomic analysis by liquid chromatography-mass spectrometry (LC-MS) and differential mRNA expression analysis by RNA-seq. Cardiac tissue was collected to assess serine protease activity, RNA, protein and cytokine expression. The results indicate that AKI significantly upregulated SerpinA3N in the heart which was negatively correlated with serine protease (Granzyme B) activity. Further, AKI induced the development of several pro-fibrotic factors, induced mitochondrial dysfunction and increased inflammation. Finally, using H9C2 cells we demonstrated that inhibiting SerpinA3N with XAV939 increased Granzyme B activity. Thus, this study suggests that AKI leads to the development of pro-fibrotic factors in the heart and disrupts cardiac remodeling by SerpinA3N mediated inhibition of serine protease Granzyme B activity. Decreased SerpinA3N expression in the heart followed by AKI could lead to a more balanced extracellular matrix (ECM) composition in the heart with an alleviated pro-fibrotic response.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

